Syncom Formulations (India) Ltd. logo

Syncom Formulations (India) Ltd. (SYNCOMF)

Market Closed
7 Aug, 22:00
MSE MSE
13. 44
+0.25
+1.8954%
- Market Cap
40 P/E Ratio
- Div Yield
225,561 Volume
0 Eps
13.19
Previous Close
Add Transaction
Day Range
13.08 13.49
Year Range
10.21 18.9
Want to track SYNCOMF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SYNCOMF closed Friday higher at ₹13.44, an increase of 1.8954% from Thursday's close, completing a monthly decrease of -6.8607% or -₹0.99. Over the past 12 months, SYNCOMF stock lost -6.0797%.
SYNCOMF is not paying dividends to its shareholders.
The last earnings report, released on May 18, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.1259%, based on the last three reports.
Syncom Formulations (India) Ltd. has completed 1 stock splits, with the recent split occurring on Aug 19, 2013.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

SYNCOMF Chart

Syncom Formulations (India) Ltd. (SYNCOMF) FAQ

What is the stock price today?

The current price is ₹13.44.

On which exchange is it traded?

Syncom Formulations (India) Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is SYNCOMF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Syncom Formulations (India) Ltd. ever had a stock split?

Syncom Formulations (India) Ltd. had 1 splits and the recent split was on Aug 19, 2013.

Syncom Formulations (India) Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Ankit Kedarmal Bankda CEO
MSE Exchange
INE312C01025 ISIN
IN Country
744 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Syncom Formulations (India) Limited is a prominent entity in the pharmaceutical industry of India, engaged in the manufacturing, marketing, and distribution of a diverse range of pharmaceutical formulation products. The company operates through multiple segments, including Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties. Established in 1988 and based in Indore, India, Syncom Formulations also extends its product reach beyond domestic markets, exporting its pharmaceutical formulations to other countries. The company's operations are not limited to pharmaceuticals alone; it also ventures into the trading of commodities and property rentals, showcasing a wide-ranging business portfolio.

Products and Services

  • Pharmaceutical Formulations:
  • Syncom Formulations (India) Limited offers an exhaustive portfolio of pharmaceutical products across various therapeutic categories. These include antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, dermatology, gastroenterology, gynecology, ophthalmology, orthopedics, and pediatrics formulations. The formulations are available in diverse dosage forms, such as tablets, capsules, liquid orals, liquid vials, ampoule injections, dry vial injections, dry syrups, ointments, inhalers, and herbal products, ensuring a comprehensive healthcare solution.

  • Specific Health Solutions:
  • The company's product range also encompasses specialized health solutions addressing specific medical conditions. These include an anemia tablet and syrup, lycopene, minerals, and vitamins capsules, products targeting the eradication of vaginal pathogens, capsules for menopause treatment, herbal uterine tonic, syrup for lactation insufficiency, cough suppressants, liver tonic, medicine for burning urination, and nutritional supplements. This array of products underscores Syncom Formulations' commitment to catering to the wide-ranging healthcare needs of its customers.

  • Trading of Commodities:
  • Beyond pharmaceuticals, Syncom Formulations engages in the trading of commodities, showcasing its versatility in business operations. This segment enables the company to diversify its revenue streams and leverage market opportunities in the trading sector.

  • Renting of Properties:
  • The company also extends its business operations to the real estate sector through the renting of properties. This not only showcases the breadth of Syncom Formulations' business interests but also contributes to its revenue through property leases.

Contact Information

Address: Syncom House, Indore, India, 452018
Phone: 91 73 1270 0458